Drug Type Small molecule drug |
Synonyms NOVO 118, NOVO118 |
Target |
Action modulators |
Mechanism LRP1 modulators(LDL receptor related protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute spinal cord injury | Clinical | United States | 20 Jul 2020 | |
Multiple Sclerosis | Discovery | United States | 20 Jul 2020 | |
Tauopathies | Discovery | United States | 20 Jul 2020 | |
Alzheimer Disease | Discovery | United States | - | |
Brain Injuries, Traumatic | Discovery | United States | - | |
Glaucoma | Discovery | United States | - |